Surveillance for severe hand, foot, and mouth disease from 2009 to 2015 in Jiangsu province: epidemiology, etiology, and disease burden
Severe hand, foot, and mouth disease (HFMD) is a common childhood illness caused by various enteroviruses. The disease has imposed increased burden on children younger than 5 years old. We aimed to determine the epidemiology, CNS complication, and etiology among severe HFMD patients, in Jiangsu, Chi...
Saved in:
| Published in | BMC infectious diseases Vol. 19; no. 1; pp. 79 - 18 |
|---|---|
| Main Authors | , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
BioMed Central Ltd
22.01.2019
BioMed Central BMC |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1471-2334 1471-2334 |
| DOI | 10.1186/s12879-018-3659-7 |
Cover
Loading…
| Abstract | Severe hand, foot, and mouth disease (HFMD) is a common childhood illness caused by various enteroviruses. The disease has imposed increased burden on children younger than 5 years old. We aimed to determine the epidemiology, CNS complication, and etiology among severe HFMD patients, in Jiangsu, China.
Epidemiological, clinical, and laboratory data of severe HFMD cases were extracted from 2009 to 2015. The CNS complication, annually severe illness rates, mortality rates, severity-PICU admission rates, severity-hospitalization rates, and so on were analyzed to assess the disease burden of severe HFMD. All analyses were stratified by time, region, population, CNS involvement and serotypes. The VP1 gene from EV-A71, CV-A16, CV-A6, CV-A10 and other enteroviruses isolates was amplified. Phylogenetic analysis was performed using MEGA5.0.
Seven thousand nine hundred ninety-four severe HFMD cases were reported, of them, 7224 cases were inpatients, 611 were PICU inpatients, and 68 were fatal. The average severe illness rate, mortality rate, severity-fatality rate, severity-PICU admission rate, and severity-hospitalization rate were 14.54, 0.12,8506, 76,430, and 903,700 per 1 million, respectively. The severe illness rate was the highest in the 12-23 months age group, and the greatest mortality rate was in the 6-11 months age group. Geographical difference in severe illness rate and mortality were found. Patients infected with EV-A71 were at a higher proportion in different CNS involvement even death. EV-A71, CV-A16 and other enteroviruses accounted for 79.14, 6.49, and 14.47%, respectively. A total of 14 non-EV-A71/ CV-A16 genotypes including CV-A2, CV-A4, CV-A 6, CV-A9, CV-A10, CV-B1, CV-B2, CV-B3, CV-B4, CV-B5, E-6, E-7, E-18, and EV-C96 were identified. Phylogentic analyses demonstrated that EV-A71 strains belonged to subgenotype C4a, while CV-A16 strains belonged to sub-genotype B1a and sub-genotype B1b of genotype B1. CV-A6 strains were assigned to genogroup F, and CV-A10 strains belonged to genogroup D.
Future mitigation policies should take into account the age, region heterogeneities, CNS conditions and serotype of disease. Additional a more rigorous study between the mild and severe HFMD should be warranted to elucidate the difference epidemiology, pathogen spectrum and immunity patterns and to optimize interventions in the following study. |
|---|---|
| AbstractList | Severe hand, foot, and mouth disease (HFMD) is a common childhood illness caused by various enteroviruses. The disease has imposed increased burden on children younger than 5 years old. We aimed to determine the epidemiology, CNS complication, and etiology among severe HFMD patients, in Jiangsu, China.
Epidemiological, clinical, and laboratory data of severe HFMD cases were extracted from 2009 to 2015. The CNS complication, annually severe illness rates, mortality rates, severity-PICU admission rates, severity-hospitalization rates, and so on were analyzed to assess the disease burden of severe HFMD. All analyses were stratified by time, region, population, CNS involvement and serotypes. The VP1 gene from EV-A71, CV-A16, CV-A6, CV-A10 and other enteroviruses isolates was amplified. Phylogenetic analysis was performed using MEGA5.0.
Seven thousand nine hundred ninety-four severe HFMD cases were reported, of them, 7224 cases were inpatients, 611 were PICU inpatients, and 68 were fatal. The average severe illness rate, mortality rate, severity-fatality rate, severity-PICU admission rate, and severity-hospitalization rate were 14.54, 0.12,8506, 76,430, and 903,700 per 1 million, respectively. The severe illness rate was the highest in the 12-23 months age group, and the greatest mortality rate was in the 6-11 months age group. Geographical difference in severe illness rate and mortality were found. Patients infected with EV-A71 were at a higher proportion in different CNS involvement even death. EV-A71, CV-A16 and other enteroviruses accounted for 79.14, 6.49, and 14.47%, respectively. A total of 14 non-EV-A71/ CV-A16 genotypes including CV-A2, CV-A4, CV-A 6, CV-A9, CV-A10, CV-B1, CV-B2, CV-B3, CV-B4, CV-B5, E-6, E-7, E-18, and EV-C96 were identified. Phylogentic analyses demonstrated that EV-A71 strains belonged to subgenotype C4a, while CV-A16 strains belonged to sub-genotype B1a and sub-genotype B1b of genotype B1. CV-A6 strains were assigned to genogroup F, and CV-A10 strains belonged to genogroup D.
Future mitigation policies should take into account the age, region heterogeneities, CNS conditions and serotype of disease. Additional a more rigorous study between the mild and severe HFMD should be warranted to elucidate the difference epidemiology, pathogen spectrum and immunity patterns and to optimize interventions in the following study. Severe hand, foot, and mouth disease (HFMD) is a common childhood illness caused by various enteroviruses. The disease has imposed increased burden on children younger than 5 years old. We aimed to determine the epidemiology, CNS complication, and etiology among severe HFMD patients, in Jiangsu, China. Epidemiological, clinical, and laboratory data of severe HFMD cases were extracted from 2009 to 2015. The CNS complication, annually severe illness rates, mortality rates, severity-PICU admission rates, severity-hospitalization rates, and so on were analyzed to assess the disease burden of severe HFMD. All analyses were stratified by time, region, population, CNS involvement and serotypes. The VP1 gene from EV-A71, CV-A16, CV-A6, CV-A10 and other enteroviruses isolates was amplified. Phylogenetic analysis was performed using MEGA5.0. Seven thousand nine hundred ninety-four severe HFMD cases were reported, of them, 7224 cases were inpatients, 611 were PICU inpatients, and 68 were fatal. The average severe illness rate, mortality rate, severity-fatality rate, severity-PICU admission rate, and severity-hospitalization rate were 14.54, 0.12,8506, 76,430, and 903,700 per 1 million, respectively. The severe illness rate was the highest in the 12-23 months age group, and the greatest mortality rate was in the 6-11 months age group. Geographical difference in severe illness rate and mortality were found. Patients infected with EV-A71 were at a higher proportion in different CNS involvement even death. EV-A71, CV-A16 and other enteroviruses accounted for 79.14, 6.49, and 14.47%, respectively. A total of 14 non-EV-A71/ CV-A16 genotypes including CV-A2, CV-A4, CV-A 6, CV-A9, CV-A10, CV-B1, CV-B2, CV-B3, CV-B4, CV-B5, E-6, E-7, E-18, and EV-C96 were identified. Phylogentic analyses demonstrated that EV-A71 strains belonged to subgenotype C4a, while CV-A16 strains belonged to sub-genotype B1a and sub-genotype B1b of genotype B1. CV-A6 strains were assigned to genogroup F, and CV-A10 strains belonged to genogroup D. Future mitigation policies should take into account the age, region heterogeneities, CNS conditions and serotype of disease. Additional a more rigorous study between the mild and severe HFMD should be warranted to elucidate the difference epidemiology, pathogen spectrum and immunity patterns and to optimize interventions in the following study. Severe hand, foot, and mouth disease (HFMD) is a common childhood illness caused by various enteroviruses. The disease has imposed increased burden on children younger than 5 years old. We aimed to determine the epidemiology, CNS complication, and etiology among severe HFMD patients, in Jiangsu, China.BACKGROUNDSevere hand, foot, and mouth disease (HFMD) is a common childhood illness caused by various enteroviruses. The disease has imposed increased burden on children younger than 5 years old. We aimed to determine the epidemiology, CNS complication, and etiology among severe HFMD patients, in Jiangsu, China.Epidemiological, clinical, and laboratory data of severe HFMD cases were extracted from 2009 to 2015. The CNS complication, annually severe illness rates, mortality rates, severity-PICU admission rates, severity-hospitalization rates, and so on were analyzed to assess the disease burden of severe HFMD. All analyses were stratified by time, region, population, CNS involvement and serotypes. The VP1 gene from EV-A71, CV-A16, CV-A6, CV-A10 and other enteroviruses isolates was amplified. Phylogenetic analysis was performed using MEGA5.0.METHODSEpidemiological, clinical, and laboratory data of severe HFMD cases were extracted from 2009 to 2015. The CNS complication, annually severe illness rates, mortality rates, severity-PICU admission rates, severity-hospitalization rates, and so on were analyzed to assess the disease burden of severe HFMD. All analyses were stratified by time, region, population, CNS involvement and serotypes. The VP1 gene from EV-A71, CV-A16, CV-A6, CV-A10 and other enteroviruses isolates was amplified. Phylogenetic analysis was performed using MEGA5.0.Seven thousand nine hundred ninety-four severe HFMD cases were reported, of them, 7224 cases were inpatients, 611 were PICU inpatients, and 68 were fatal. The average severe illness rate, mortality rate, severity-fatality rate, severity-PICU admission rate, and severity-hospitalization rate were 14.54, 0.12,8506, 76,430, and 903,700 per 1 million, respectively. The severe illness rate was the highest in the 12-23 months age group, and the greatest mortality rate was in the 6-11 months age group. Geographical difference in severe illness rate and mortality were found. Patients infected with EV-A71 were at a higher proportion in different CNS involvement even death. EV-A71, CV-A16 and other enteroviruses accounted for 79.14, 6.49, and 14.47%, respectively. A total of 14 non-EV-A71/ CV-A16 genotypes including CV-A2, CV-A4, CV-A 6, CV-A9, CV-A10, CV-B1, CV-B2, CV-B3, CV-B4, CV-B5, E-6, E-7, E-18, and EV-C96 were identified. Phylogentic analyses demonstrated that EV-A71 strains belonged to subgenotype C4a, while CV-A16 strains belonged to sub-genotype B1a and sub-genotype B1b of genotype B1. CV-A6 strains were assigned to genogroup F, and CV-A10 strains belonged to genogroup D.RESULTSSeven thousand nine hundred ninety-four severe HFMD cases were reported, of them, 7224 cases were inpatients, 611 were PICU inpatients, and 68 were fatal. The average severe illness rate, mortality rate, severity-fatality rate, severity-PICU admission rate, and severity-hospitalization rate were 14.54, 0.12,8506, 76,430, and 903,700 per 1 million, respectively. The severe illness rate was the highest in the 12-23 months age group, and the greatest mortality rate was in the 6-11 months age group. Geographical difference in severe illness rate and mortality were found. Patients infected with EV-A71 were at a higher proportion in different CNS involvement even death. EV-A71, CV-A16 and other enteroviruses accounted for 79.14, 6.49, and 14.47%, respectively. A total of 14 non-EV-A71/ CV-A16 genotypes including CV-A2, CV-A4, CV-A 6, CV-A9, CV-A10, CV-B1, CV-B2, CV-B3, CV-B4, CV-B5, E-6, E-7, E-18, and EV-C96 were identified. Phylogentic analyses demonstrated that EV-A71 strains belonged to subgenotype C4a, while CV-A16 strains belonged to sub-genotype B1a and sub-genotype B1b of genotype B1. CV-A6 strains were assigned to genogroup F, and CV-A10 strains belonged to genogroup D.Future mitigation policies should take into account the age, region heterogeneities, CNS conditions and serotype of disease. Additional a more rigorous study between the mild and severe HFMD should be warranted to elucidate the difference epidemiology, pathogen spectrum and immunity patterns and to optimize interventions in the following study.CONCLUSIONSFuture mitigation policies should take into account the age, region heterogeneities, CNS conditions and serotype of disease. Additional a more rigorous study between the mild and severe HFMD should be warranted to elucidate the difference epidemiology, pathogen spectrum and immunity patterns and to optimize interventions in the following study. Background Severe hand, foot, and mouth disease (HFMD) is a common childhood illness caused by various enteroviruses. The disease has imposed increased burden on children younger than 5 years old. We aimed to determine the epidemiology, CNS complication, and etiology among severe HFMD patients, in Jiangsu, China. Methods Epidemiological, clinical, and laboratory data of severe HFMD cases were extracted from 2009 to 2015. The CNS complication, annually severe illness rates, mortality rates, severity-PICU admission rates, severity-hospitalization rates, and so on were analyzed to assess the disease burden of severe HFMD. All analyses were stratified by time, region, population, CNS involvement and serotypes. The VP1 gene from EV-A71, CV-A16, CV-A6, CV-A10 and other enteroviruses isolates was amplified. Phylogenetic analysis was performed using MEGA5.0. Results Seven thousand nine hundred ninety-four severe HFMD cases were reported, of them, 7224 cases were inpatients, 611 were PICU inpatients, and 68 were fatal. The average severe illness rate, mortality rate, severity-fatality rate, severity-PICU admission rate, and severity-hospitalization rate were 14.54, 0.12,8506, 76,430, and 903,700 per 1 million, respectively. The severe illness rate was the highest in the 12-23 months age group, and the greatest mortality rate was in the 6-11 months age group. Geographical difference in severe illness rate and mortality were found. Patients infected with EV-A71 were at a higher proportion in different CNS involvement even death. EV-A71, CV-A16 and other enteroviruses accounted for 79.14, 6.49, and 14.47%, respectively. A total of 14 non-EV-A71/ CV-A16 genotypes including CV-A2, CV-A4, CV-A 6, CV-A9, CV-A10, CV-B1, CV-B2, CV-B3, CV-B4, CV-B5, E-6, E-7, E-18, and EV-C96 were identified. Phylogentic analyses demonstrated that EV-A71 strains belonged to subgenotype C4a, while CV-A16 strains belonged to sub-genotype B1a and sub-genotype B1b of genotype B1. CV-A6 strains were assigned to genogroup F, and CV-A10 strains belonged to genogroup D. Conclusions Future mitigation policies should take into account the age, region heterogeneities, CNS conditions and serotype of disease. Additional a more rigorous study between the mild and severe HFMD should be warranted to elucidate the difference epidemiology, pathogen spectrum and immunity patterns and to optimize interventions in the following study. Keywords: Severe hand, foot and mouth disease, Epidemiology, Disease burden, CNS complication, Enterovirus A71, Coxsackievirus A16, Coxsackievirus A6, Coxsackievirus A10, Pathogen spectrum Abstract Background Severe hand, foot, and mouth disease (HFMD) is a common childhood illness caused by various enteroviruses. The disease has imposed increased burden on children younger than 5 years old. We aimed to determine the epidemiology, CNS complication, and etiology among severe HFMD patients, in Jiangsu, China. Methods Epidemiological, clinical, and laboratory data of severe HFMD cases were extracted from 2009 to 2015. The CNS complication, annually severe illness rates, mortality rates, severity-PICU admission rates, severity-hospitalization rates, and so on were analyzed to assess the disease burden of severe HFMD. All analyses were stratified by time, region, population, CNS involvement and serotypes. The VP1 gene from EV-A71, CV-A16, CV-A6, CV-A10 and other enteroviruses isolates was amplified. Phylogenetic analysis was performed using MEGA5.0. Results Seven thousand nine hundred ninety-four severe HFMD cases were reported, of them, 7224 cases were inpatients, 611 were PICU inpatients, and 68 were fatal. The average severe illness rate, mortality rate, severity−fatality rate, severity-PICU admission rate, and severity-hospitalization rate were 14.54, 0.12,8506, 76,430, and 903,700 per 1 million, respectively. The severe illness rate was the highest in the 12–23 months age group, and the greatest mortality rate was in the 6–11 months age group. Geographical difference in severe illness rate and mortality were found. Patients infected with EV-A71 were at a higher proportion in different CNS involvement even death. EV-A71, CV-A16 and other enteroviruses accounted for 79.14, 6.49, and 14.47%, respectively. A total of 14 non-EV-A71/ CV-A16 genotypes including CV-A2, CV-A4, CV-A 6, CV-A9, CV-A10, CV-B1, CV-B2, CV-B3, CV-B4, CV-B5, E-6, E-7, E-18, and EV-C96 were identified. Phylogentic analyses demonstrated that EV-A71 strains belonged to subgenotype C4a, while CV-A16 strains belonged to sub-genotype B1a and sub-genotype B1b of genotype B1. CV-A6 strains were assigned to genogroup F, and CV-A10 strains belonged to genogroup D. Conclusions Future mitigation policies should take into account the age, region heterogeneities, CNS conditions and serotype of disease. Additional a more rigorous study between the mild and severe HFMD should be warranted to elucidate the difference epidemiology, pathogen spectrum and immunity patterns and to optimize interventions in the following study. |
| ArticleNumber | 79 |
| Audience | Academic |
| Author | Fan, Huan Ai, Jing Zhang, Xue-Feng Jin, Yu Huo, Xiang Bao, Chang-jun Shan, Jun Shi, Chao Ji, Hong Lu, Peng-xiao |
| Author_xml | – sequence: 1 givenname: Hong surname: Ji fullname: Ji, Hong – sequence: 2 givenname: Huan surname: Fan fullname: Fan, Huan – sequence: 3 givenname: Peng-xiao surname: Lu fullname: Lu, Peng-xiao – sequence: 4 givenname: Xue-Feng surname: Zhang fullname: Zhang, Xue-Feng – sequence: 5 givenname: Jing surname: Ai fullname: Ai, Jing – sequence: 6 givenname: Chao surname: Shi fullname: Shi, Chao – sequence: 7 givenname: Xiang surname: Huo fullname: Huo, Xiang – sequence: 8 givenname: Chang-jun surname: Bao fullname: Bao, Chang-jun – sequence: 9 givenname: Jun surname: Shan fullname: Shan, Jun – sequence: 10 givenname: Yu surname: Jin fullname: Jin, Yu |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30669973$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkl2L1DAUhousuB_6A7yRgDcK0zVJ06T1QlgWP0YWFlz1NpxJTzpZOs1s0g7uL_Bvm-7syI4oSC9yOH3OQzh5j7OD3veYZc8ZPWWskm8i45Wqc8qqvJBlnatH2RETiuW8KMTBg_owO47xmlKmKl4_yQ4LKmVdq-Io-3k1hg26roPeILE-kIgbDEiW0Dez1PDDjKSSrPw4LEnjIkJMYPArwimtyeDTyUrievLZQd_GkayD37ike0tw7RpcOd_59nZGcNhVk3CnWoyhwf5p9thCF_HZ_XmSffvw_uv5p_zi8uP8_OwiN1LKIRdGlZILbqRgCKwEZZStLDULWhSUG8UBy8rWIKuiXoARyBEWvAFRUsTSFifZfOttPFzrdXArCLfag9N3DR9aDWFwpkPNLDcMqAWorGhSaWXZyIqBUdg0XCTXu61rPS5W2BjshwDdnnT_T--WuvUbLQvB5J3g1b0g-JsR46BXLhqcHgP9GDVnqhaMClon9OUWbSFdzfXWJ6OZcH1WVkxwKZRM1OlfqPRNr2BSeKxL_b2B13sDiRnwx9DCGKOeX335f_by-z774uFqfu9kF7wEqC1ggo8xoNXGDZACMm3KdZpRPUVcbyOuU8T1FHGt0iT7Y3In__fML6CQ_Ew |
| CitedBy_id | crossref_primary_10_1002_rmv_2087 crossref_primary_10_1186_s12889_022_13860_z crossref_primary_10_1016_j_ijid_2021_11_026 crossref_primary_10_1186_s13690_022_00974_4 crossref_primary_10_1016_j_virol_2020_07_003 crossref_primary_10_1080_22221751_2022_2125346 crossref_primary_10_1002_jmv_29707 crossref_primary_10_3390_v15010075 crossref_primary_10_1017_S0950268823000389 crossref_primary_10_1080_22221751_2019_1673135 crossref_primary_10_1007_s00705_020_04536_3 crossref_primary_10_1080_21645515_2020_1737465 crossref_primary_10_1007_s00705_021_05128_5 crossref_primary_10_1016_j_virusres_2023_199235 crossref_primary_10_3389_fmicb_2023_1172349 crossref_primary_10_1186_s12879_020_04992_x crossref_primary_10_1186_s12879_022_07661_3 crossref_primary_10_1186_s13690_021_00688_z crossref_primary_10_3389_fmicb_2021_811553 crossref_primary_10_1186_s12199_020_00927_9 crossref_primary_10_1038_s41598_021_84891_6 crossref_primary_10_31631_2073_3046_2019_18_5_33_41 crossref_primary_10_1097_INF_0000000000002985 crossref_primary_10_1080_21645515_2022_2049168 crossref_primary_10_1002_jmv_27657 crossref_primary_10_1002_jmv_28669 crossref_primary_10_3390_v15102114 crossref_primary_10_1016_j_scitotenv_2023_165926 crossref_primary_10_1186_s12920_021_01107_6 crossref_primary_10_35627_2219_5238_2021_337_4_43_49 crossref_primary_10_1007_s12250_021_00444_1 crossref_primary_10_3390_microorganisms10010112 crossref_primary_10_1016_j_scitotenv_2025_178896 crossref_primary_10_1016_j_virs_2022_01_028 crossref_primary_10_3389_fpubh_2024_1377861 crossref_primary_10_1007_s12560_020_09449_7 crossref_primary_10_1007_s00705_020_04734_z crossref_primary_10_1080_21645515_2021_1978792 crossref_primary_10_1038_s41467_019_13936_2 |
| Cites_doi | 10.1056/NEJMoa065954 10.1186/1743-422X-9-248 10.1007/s00705-006-0934-5 10.1161/CIRCULATIONAHA.112.000602 10.1371/journal.pone.0083711 10.1086/605090 10.4103/0378-6323.107631 10.1371/journal.pone.0131311 10.3201/eid0904.020395 10.1002/jmv.24275 10.3201/eid1802.111147 10.1542/peds.109.6.e88 10.1016/S0140-6736(13)61049-1 10.1186/1471-2458-6-180 10.1016/S1386-6532(01)00214-1 10.1007/s11262-011-0584-x 10.1016/S1473-3099(10)70194-8 10.1371/journal.pone.0037206 10.4269/ajtmh.2007.77.188 10.1037/e540562006-001 10.1016/j.meegid.2013.02.011 10.1002/jmv.21122 10.1186/1471-2334-11-346 10.1016/j.jmii.2011.01.031 10.1128/JCM.02338-09 10.1016/j.jcv.2009.02.002 10.1371/journal.pone.0142733 10.1097/INF.0b013e3181a41d63 10.1542/peds.2006-3331 10.1086/314032 10.1099/jmm.0.027698-0 10.1093/molbev/msr121 10.3201/eid1509.090438 10.1128/JVI.73.12.9969-9975.1999 10.47102/annals-acadmedsg.V38N2p106 10.1016/S1474-4422(10)70209-X 10.1038/srep08904 10.1007/s00705-015-2350-1 10.1371/journal.pone.0138514 10.1016/j.ajic.2013.02.014 10.1128/JVI.01808-12 10.1128/JVI.01709-12 10.1097/EDE.0b013e318231d67a 10.1371/journal.pone.0052073 10.1016/S1473-3099(13)70264-0 10.1093/cid/ciu624 10.1371/journal.pone.0086877 10.1002/jmv.21707 10.1002/rmv.1827 10.1590/S1517-83822008000100007 10.1016/S1386-6532(03)00004-0 10.1056/NEJM199909233411302 10.1186/1743-422X-11-157 10.1056/NEJMoa1304923 10.1016/S1473-3099(13)70342-6 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2019 BioMed Central Ltd. The Author(s). 2019 |
| Copyright_xml | – notice: COPYRIGHT 2019 BioMed Central Ltd. – notice: The Author(s). 2019 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 7X8 5PM DOA |
| DOI | 10.1186/s12879-018-3659-7 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Science MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Open Access Full Text url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1471-2334 |
| EndPage | 18 |
| ExternalDocumentID | oai_doaj_org_article_1f2c1a0faa8f4dc1af65d681ac7edd24 PMC6341624 A581426476 30669973 10_1186_s12879_018_3659_7 |
| Genre | Journal Article |
| GeographicLocations | China |
| GeographicLocations_xml | – name: China |
| GrantInformation_xml | – fundername: Jiangsu Province Science & Technology Demonstration Project for Emerging Infectious Diseases Control and Prevention grantid: BE2015714 – fundername: National Natural Science Foundation of China grantid: 81402732 – fundername: Scientific and technological development foundation of Wuxi grantid: CSE31N1515 – fundername: National Natural Science Foundation of China grantid: 81672020 – fundername: ; grantid: BE2015714 – fundername: ; grantid: 81402732; 81672020 – fundername: ; grantid: CSE31N1515 |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7X7 88E 8C1 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR IOV ISR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB -A0 3V. ACRMQ ADINQ C24 CGR CUY CVF ECM EIF NPM PMFND 7X8 PJZUB PPXIY PUEGO 5PM |
| ID | FETCH-LOGICAL-c666t-4c756242c641ea15a7c7f8f0cb03302c72ae58f9a6839bac4e2eab2da450ee5f3 |
| IEDL.DBID | M48 |
| ISSN | 1471-2334 |
| IngestDate | Wed Aug 27 00:43:08 EDT 2025 Thu Aug 21 18:32:11 EDT 2025 Sun Aug 24 03:56:40 EDT 2025 Tue Jun 17 21:46:31 EDT 2025 Tue Jun 10 20:29:07 EDT 2025 Fri Jun 27 04:22:32 EDT 2025 Fri Jun 27 05:11:28 EDT 2025 Thu Jan 02 22:59:22 EST 2025 Thu Apr 24 23:01:36 EDT 2025 Tue Jul 01 01:57:34 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Coxsackievirus A6 Coxsackievirus A10 CNS complication Enterovirus A71 Disease burden Epidemiology Coxsackievirus A16 Pathogen spectrum Severe hand, foot and mouth disease |
| Language | English |
| License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c666t-4c756242c641ea15a7c7f8f0cb03302c72ae58f9a6839bac4e2eab2da450ee5f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://doaj.org/article/1f2c1a0faa8f4dc1af65d681ac7edd24 |
| PMID | 30669973 |
| PQID | 2179410409 |
| PQPubID | 23479 |
| PageCount | 18 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_1f2c1a0faa8f4dc1af65d681ac7edd24 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6341624 proquest_miscellaneous_2179410409 gale_infotracmisc_A581426476 gale_infotracacademiconefile_A581426476 gale_incontextgauss_ISR_A581426476 gale_incontextgauss_IOV_A581426476 pubmed_primary_30669973 crossref_citationtrail_10_1186_s12879_018_3659_7 crossref_primary_10_1186_s12879_018_3659_7 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2019-01-22 |
| PublicationDateYYYYMMDD | 2019-01-22 |
| PublicationDate_xml | – month: 01 year: 2019 text: 2019-01-22 day: 22 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | BMC infectious diseases |
| PublicationTitleAlternate | BMC Infect Dis |
| PublicationYear | 2019 |
| Publisher | BioMed Central Ltd BioMed Central BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
| References | R Osterback (3659_CR42) 2009; 15 W Xing (3659_CR20) 2014; 14 3659_CR23 3659_CR24 LC Lum (3659_CR60) 2002; 23 F Zhu (3659_CR34) 2014; 370 SC Chen (3659_CR17) 2007; 77 YF Hu (3659_CR52) 2012; 86 N Saitou (3659_CR27) 1987; 4 LY Chang (3659_CR35) 2007; 356 A Luchs (3659_CR57) 2008; 39 T Fujimoto (3659_CR15) 2012; 18 SH Lo (3659_CR46) 2011; 44 N Mao (3659_CR59) 2010; 82 T Bingjun (3659_CR64) 2008; 80 FC Zhu (3659_CR33) 2013; 381 YF Hu (3659_CR55) 2012; 86 T Solomon (3659_CR5) 2010; 10 N Sarma (3659_CR7) 2013; 79 Y Zhang (3659_CR41) 2010; 48 ME Wikswo (3659_CR50) 2009; 49 MH Ooi (3659_CR1) 2010; 9 MJ Cardosa (3659_CR8) 2003; 9 FC Zhu (3659_CR31) 2012; 7 HP Tsai (3659_CR61) 2011; 60 K Tamura (3659_CR26) 2011; 28 3659_CR12 G Turabelidze (3659_CR62) 2009; 106 HM Feder Jr (3659_CR44) 2014; 14 X Yao (3659_CR11) 2015; 160 C Zhang (3659_CR49) 2015; 4 YF Hu (3659_CR51) 2012; 65 N Siafakas (3659_CR56) 2013; 41 D Perera (3659_CR40) 2007; 152 3659_CR53 URING APRIL-July (3659_CR3) 1998; 47 H Guan (3659_CR14) 2015; 10 J Li (3659_CR45) 2016; 7 T Ikeda (3659_CR54) 2013; 128 QB Lu (3659_CR19) 2012; 7 3659_CR48 LW Ang (3659_CR29) 2009; 38 B Di (3659_CR13) 2014; 11 MS Oberste (3659_CR25) 2003; 26 Y Podin (3659_CR28) 2006; 6 LG Chan (3659_CR2) 2000; 31 J Lu (3659_CR63) 2014; 9 W Liu (3659_CR16) 2015; 10 KT Chen (3659_CR22) 2007; 120 H Ji (3659_CR32) 2012; 9 CC Huang (3659_CR4) 1999; 341 X Yao (3659_CR10) 2015; 87 LY Chang (3659_CR18) 2002; 109 WH Wu (3659_CR39) 2013; 8 Y Zhang (3659_CR37) 2009; 44 3659_CR38 F Yang (3659_CR47) 2014; 59 SH Wei (3659_CR43) 2011; 11 X Huang (3659_CR21) 2015; 5 A Xu (3659_CR65) 2011; 42 SL Liu (3659_CR30) 2015; 25 TC Lee (3659_CR6) 2009; 28 Y Wang (3659_CR9) 2011; 22 T Smura (3659_CR58) 2013; 16 BA Brown (3659_CR36) 1999; 73 |
| References_xml | – volume: 356 start-page: 1226 issue: 12 year: 2007 ident: 3659_CR35 publication-title: N Engl J Med doi: 10.1056/NEJMoa065954 – volume: 9 start-page: 248 year: 2012 ident: 3659_CR32 publication-title: Virol J doi: 10.1186/1743-422X-9-248 – volume: 152 start-page: 1201 issue: 6 year: 2007 ident: 3659_CR40 publication-title: Arch Virol doi: 10.1007/s00705-006-0934-5 – volume: 128 start-page: 2811 issue: 25 year: 2013 ident: 3659_CR54 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.112.000602 – volume: 8 issue: 12 year: 2013 ident: 3659_CR39 publication-title: PLoS One doi: 10.1371/journal.pone.0083711 – volume: 49 start-page: e44 issue: 5 year: 2009 ident: 3659_CR50 publication-title: Clin Infect Dis doi: 10.1086/605090 – volume: 79 start-page: 165 issue: 2 year: 2013 ident: 3659_CR7 publication-title: Indian J Dermatol Venereol Leprol doi: 10.4103/0378-6323.107631 – volume: 7 start-page: 391 year: 2016 ident: 3659_CR45 publication-title: Front Microbiol – volume: 10 issue: 6 year: 2015 ident: 3659_CR16 publication-title: PLoS One doi: 10.1371/journal.pone.0131311 – volume: 9 start-page: 461 issue: 4 year: 2003 ident: 3659_CR8 publication-title: Emerg Infect Dis doi: 10.3201/eid0904.020395 – volume: 87 start-page: 2009 issue: 12 year: 2015 ident: 3659_CR10 publication-title: J Med Virol doi: 10.1002/jmv.24275 – volume: 18 start-page: 337 issue: 2 year: 2012 ident: 3659_CR15 publication-title: Emerg Infect Dis doi: 10.3201/eid1802.111147 – volume: 109 start-page: e88 issue: 6 year: 2002 ident: 3659_CR18 publication-title: Pediatrics doi: 10.1542/peds.109.6.e88 – volume: 381 start-page: 2024 issue: 9882 year: 2013 ident: 3659_CR33 publication-title: Lancet doi: 10.1016/S0140-6736(13)61049-1 – volume: 6 start-page: 180 year: 2006 ident: 3659_CR28 publication-title: BMC Public Health doi: 10.1186/1471-2458-6-180 – volume: 23 start-page: 153 issue: 3 year: 2002 ident: 3659_CR60 publication-title: J Clin Virol doi: 10.1016/S1386-6532(01)00214-1 – volume: 42 start-page: 323 issue: 3 year: 2011 ident: 3659_CR65 publication-title: Virus Genes doi: 10.1007/s11262-011-0584-x – volume: 10 start-page: 778 issue: 11 year: 2010 ident: 3659_CR5 publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(10)70194-8 – volume: 7 start-page: e37206 issue: 5 year: 2012 ident: 3659_CR31 publication-title: PLoS One doi: 10.1371/journal.pone.0037206 – volume: 77 start-page: 188 issue: 1 year: 2007 ident: 3659_CR17 publication-title: Am J Trop Med Hyg doi: 10.4269/ajtmh.2007.77.188 – ident: 3659_CR53 doi: 10.1037/e540562006-001 – ident: 3659_CR23 – volume: 16 start-page: 234 year: 2013 ident: 3659_CR58 publication-title: Infect Genet Evol doi: 10.1016/j.meegid.2013.02.011 – volume: 80 start-page: 670 issue: 4 year: 2008 ident: 3659_CR64 publication-title: J Med Virol doi: 10.1002/jmv.21122 – ident: 3659_CR48 – volume: 11 start-page: 346 year: 2011 ident: 3659_CR43 publication-title: BMC Infect Dis doi: 10.1186/1471-2334-11-346 – volume: 47 start-page: 629 issue: 30 year: 1998 ident: 3659_CR3 publication-title: Morb Mortal Wkly Rep – volume: 44 start-page: 252 issue: 4 year: 2011 ident: 3659_CR46 publication-title: J Microbiol Immunol Infect doi: 10.1016/j.jmii.2011.01.031 – volume: 48 start-page: 619 issue: 2 year: 2010 ident: 3659_CR41 publication-title: J Clin Microbiol doi: 10.1128/JCM.02338-09 – volume: 44 start-page: 262 issue: 4 year: 2009 ident: 3659_CR37 publication-title: J Clin Virol doi: 10.1016/j.jcv.2009.02.002 – volume: 65 start-page: 189 issue: 2 year: 2012 ident: 3659_CR51 publication-title: J Inf Secur – volume: 10 issue: 11 year: 2015 ident: 3659_CR14 publication-title: PLoS One doi: 10.1371/journal.pone.0142733 – volume: 28 start-page: 904 issue: 10 year: 2009 ident: 3659_CR6 publication-title: Pediatr Infect Dis J doi: 10.1097/INF.0b013e3181a41d63 – volume: 120 start-page: e244 issue: 2 year: 2007 ident: 3659_CR22 publication-title: Pediatrics doi: 10.1542/peds.2006-3331 – volume: 4 start-page: e12 issue: 2 year: 2015 ident: 3659_CR49 publication-title: Emerg Microbes Infect – volume: 31 start-page: 678 issue: 3 year: 2000 ident: 3659_CR2 publication-title: Clin Infect Dis doi: 10.1086/314032 – volume: 4 start-page: 406 issue: 4 year: 1987 ident: 3659_CR27 publication-title: Mol Biol Evol – volume: 60 start-page: 1360 issue: Pt 9 year: 2011 ident: 3659_CR61 publication-title: J Med Microbiol doi: 10.1099/jmm.0.027698-0 – ident: 3659_CR24 – volume: 28 start-page: 2731 issue: 10 year: 2011 ident: 3659_CR26 publication-title: Mol Biol Evol doi: 10.1093/molbev/msr121 – volume: 15 start-page: 1485 issue: 9 year: 2009 ident: 3659_CR42 publication-title: Emerg Infect Dis doi: 10.3201/eid1509.090438 – volume: 73 start-page: 9969 issue: 12 year: 1999 ident: 3659_CR36 publication-title: J Virol doi: 10.1128/JVI.73.12.9969-9975.1999 – volume: 38 start-page: 106 issue: 2 year: 2009 ident: 3659_CR29 publication-title: Ann Acad Med Singap doi: 10.47102/annals-acadmedsg.V38N2p106 – volume: 9 start-page: 1097 issue: 11 year: 2010 ident: 3659_CR1 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(10)70209-X – volume: 5 start-page: 8904 year: 2015 ident: 3659_CR21 publication-title: Sci Rep doi: 10.1038/srep08904 – volume: 160 start-page: 1291 issue: 5 year: 2015 ident: 3659_CR11 publication-title: Arch Virol doi: 10.1007/s00705-015-2350-1 – ident: 3659_CR38 doi: 10.1371/journal.pone.0138514 – volume: 41 start-page: 1125 issue: 11 year: 2013 ident: 3659_CR56 publication-title: Am J Infect Control doi: 10.1016/j.ajic.2013.02.014 – volume: 86 start-page: 10901 issue: 19 year: 2012 ident: 3659_CR55 publication-title: J Virol doi: 10.1128/JVI.01808-12 – volume: 86 start-page: 11408 issue: 20 year: 2012 ident: 3659_CR52 publication-title: J Virol doi: 10.1128/JVI.01709-12 – ident: 3659_CR12 doi: 10.1186/1471-2334-11-346 – volume: 22 start-page: 781 issue: 6 year: 2011 ident: 3659_CR9 publication-title: Epidemiology doi: 10.1097/EDE.0b013e318231d67a – volume: 7 issue: 12 year: 2012 ident: 3659_CR19 publication-title: PLoS One doi: 10.1371/journal.pone.0052073 – volume: 14 start-page: 83 issue: 1 year: 2014 ident: 3659_CR44 publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(13)70264-0 – volume: 59 start-page: 1504 issue: 10 year: 2014 ident: 3659_CR47 publication-title: Clin Infect Dis doi: 10.1093/cid/ciu624 – volume: 9 start-page: e86877 issue: 1 year: 2014 ident: 3659_CR63 publication-title: PLoS One doi: 10.1371/journal.pone.0086877 – volume: 82 start-page: 441 issue: 3 year: 2010 ident: 3659_CR59 publication-title: J Med Virol doi: 10.1002/jmv.21707 – volume: 25 start-page: 115 issue: 2 year: 2015 ident: 3659_CR30 publication-title: Rev Med Virol doi: 10.1002/rmv.1827 – volume: 39 start-page: 28 issue: 1 year: 2008 ident: 3659_CR57 publication-title: Braz J Microbiol doi: 10.1590/S1517-83822008000100007 – volume: 106 start-page: 420 issue: 6 year: 2009 ident: 3659_CR62 publication-title: Mo Med – volume: 26 start-page: 375 issue: 3 year: 2003 ident: 3659_CR25 publication-title: J Clin Virol doi: 10.1016/S1386-6532(03)00004-0 – volume: 341 start-page: 936 issue: 13 year: 1999 ident: 3659_CR4 publication-title: N Engl J Med doi: 10.1056/NEJM199909233411302 – volume: 11 start-page: 157 year: 2014 ident: 3659_CR13 publication-title: Virol J doi: 10.1186/1743-422X-11-157 – volume: 370 start-page: 818 issue: 9 year: 2014 ident: 3659_CR34 publication-title: N Engl J Med doi: 10.1056/NEJMoa1304923 – volume: 14 start-page: 308 issue: 4 year: 2014 ident: 3659_CR20 publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(13)70342-6 |
| SSID | ssj0017829 |
| Score | 2.4451766 |
| Snippet | Severe hand, foot, and mouth disease (HFMD) is a common childhood illness caused by various enteroviruses. The disease has imposed increased burden on children... Background Severe hand, foot, and mouth disease (HFMD) is a common childhood illness caused by various enteroviruses. The disease has imposed increased burden... Abstract Background Severe hand, foot, and mouth disease (HFMD) is a common childhood illness caused by various enteroviruses. The disease has imposed... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 79 |
| SubjectTerms | Analysis Case studies Child Child health Child, Preschool China - epidemiology CNS complication Coxsackievirus A16 Coxsackievirus infections Disease burden Enterovirus - genetics Enterovirus - isolation & purification Enterovirus - pathogenicity Enterovirus A71 Epidemiology Etiology (Medicine) Female Genes Genotype Genotypes Hand, Foot and Mouth Disease - complications Hand, Foot and Mouth Disease - epidemiology Hand, Foot and Mouth Disease - etiology Hospitalization - statistics & numerical data Humans Infant Male Medical research Mortality Pediatric diseases Phylogeny Risk factors Serogroup Severe hand, foot and mouth disease Viral Proteins - genetics |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Ni9UwEA-yB_EifltdJYogyCvbtPmqt1Vc1oVVcF3ZW0jTZHdBW3ltBf8C_21n2vT5iqgXTy8080o7M8nMdCa_IeQZxFsWzGxIgxUi5a4WCHlbpLzWQirGbBjTBcfv5OEpPzoTZ1utvrAmbIIHnhi3x0LumM2CtTrwGoZBilpqZp3ydZ2PSKBg8-ZgKuYPwO6VMYfJtNzrYBdWWBek00KKMlULKzSC9f--JW_ZpGW95JYBOrhBrkfPke5PT3yTXPHNLXL1OObGb5MfJ8P6m8cmQiBHCr4oBaPn157it_EVXGj7FYUh_YJd82jMzFA8X0IxeUH7Fn6ZoJcNPQKlOe8GOn1wcP4l9b86yX5fUd_PI7zhfKtqPBJxh5wevPn4-jCNbRZSB7FLDwJSAk-JOMmZt0xY5VTQIXNVVhRZ7lRuvdChtBKcqco67nNvq7y2XGTei1DcJTtN2_j7hPIASzooUfFaclVnuqxKkXswgMxrpauEZDPbjYsY5NgK47MZYxEtzSQpA5IyKCmjEvJi85evEwDH34hfoSw3hIidPV4AjTJRo8y_NCohT1ETDKJjNFh-c26HrjNv338y-0IzdCGV_BPRyYcF0fNIFFp4TWfjkQdgFqJuLSh3F5Swxt1i-smslQansDCu8e3QmRw3VAipszIh9yYt3bw9RIOyLFWRELXQ3wV7ljPN5cUIMS7BuQGdePA_-PmQXAPtxdWX5vku2enXg38EnlxfPR4X7U8uk0Xe priority: 102 providerName: Directory of Open Access Journals |
| Title | Surveillance for severe hand, foot, and mouth disease from 2009 to 2015 in Jiangsu province: epidemiology, etiology, and disease burden |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/30669973 https://www.proquest.com/docview/2179410409 https://pubmed.ncbi.nlm.nih.gov/PMC6341624 https://doaj.org/article/1f2c1a0faa8f4dc1af65d681ac7edd24 |
| Volume | 19 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR1raxNBcOkDxC_i22gNqwiC5PQe-zpBpCkttZAqqZHgl2VvbzcW6p3mLmJ_gX_bmcsl7WEV_HJZbicLN4-dmZ2dGUKegb9lQM36wBvOA2ZzjiVvk4DligsZRcY34YLRsTicsKMpn26QVXurFoHVla4d9pOazM9e_vx-_hYE_k0j8Eq8qmCPlXjrRwWJ4GkgN8k2KCaJnRxG7CKoAMowbZKNZBTEScLaIOeVS3TUVFPN_889-5LS6l6ovKShDm6SG61pSXeXvHCLbLjiNrk2aoPnd8ivk8X8h8MuQ0BoCsYqBa3o5o7i4fkAXpT1gMKQfsW2erQN3VBMQKEY3aB1Cb8Rp6cFPQKumlULujyRsO41dRetZs8H1NWrES64WiprcibuksnB_se9w6DtwxBYcG5qoKDkmEZiBYucibiRVnrlQ5uFSRLGVsbGceVTI8DayoxlLnYmi3PDeOgc98k9slWUhXtAKPMg817yjOWCyTxUaZby2AFFIqekynokXKFd27ZIOfbKONONs6KEXlJKA6U0UkrLHnmx_su3ZYWOfwEPkZZrQCyu3bwo5zPdyqqOfGwjE3pjlGc5DL3guVCRsdLlecx65ClygsbyGQXez5mZRVXpd-8_6V2uIrQxpfgb0Mm4A_S8BfIlfKY1bU4EIAvLcnUgdzqQsAnYzvSTFVdqnMKbc4UrF5WOcccFnztMe-T-kkvXXw_uokhTmfSI7PBvBz3dmeL0S1ODXID1Azzx8H-Q_4hcBy5FKQvieIds1fOFewwmXZ31yaacSniqvahPtof7xx_G_eZ4pN-IMDzHw8-_AV5OSWc |
| linkProvider | Scholars Portal |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Surveillance+for+severe+hand%2C+foot%2C+and+mouth+disease+from+2009+to+2015+in+Jiangsu+province%3A+epidemiology%2C+etiology%2C+and+disease+burden&rft.jtitle=BMC+infectious+diseases&rft.au=Ji%2C+Hong&rft.au=Fan%2C+Huan&rft.au=Lu%2C+Peng-xiao&rft.au=Zhang%2C+Xue-Feng&rft.date=2019-01-22&rft.issn=1471-2334&rft.eissn=1471-2334&rft.volume=19&rft.issue=1&rft_id=info:doi/10.1186%2Fs12879-018-3659-7&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s12879_018_3659_7 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2334&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2334&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2334&client=summon |